Omeros to Present at the 2018 Wedbush PacGrow Healthcare Conference
August 10 2018 - 7:00AM
Business Wire
Omeros Corporation (NASDAQ: OMER), today announced that Gregory
A. Demopulos, M.D., chairman and chief executive officer, will
present at the 2018 Wedbush PacGrow Healthcare Conference in New
York next week. The presentation is scheduled for Tuesday, August
14, 2018 at 2:30 p.m. EDT.
The presentation will be webcast. The live and archived webcasts
can be accessed on the “Events” page of the company’s website at
www.omeros.com.
About Omeros CorporationOmeros is a commercial-stage
biopharmaceutical company committed to discovering, developing and
commercializing small-molecule and protein therapeutics for
large-market as well as orphan indications targeting inflammation,
complement-mediated diseases and disorders of the central nervous
system. The company’s drug product OMIDRIA® (phenylephrine and
ketorolac intraocular solution) 1% / 0.3% is marketed for use
during cataract surgery or intraocular lens (IOL) replacement to
maintain pupil size by preventing intraoperative miosis (pupil
constriction) and to reduce postoperative ocular pain. In the
European Union, the European Commission has approved OMIDRIA for
use in cataract surgery and other IOL replacement procedures to
maintain mydriasis (pupil dilation), prevent miosis (pupil
constriction), and to reduce postoperative eye pain. Omeros has
multiple Phase 3 and Phase 2 clinical-stage development programs
focused on: complement-associated thrombotic microangiopathies;
complement-mediated glomerulonephropathies; cognitive impairment;
and addictive and compulsive disorders. In addition, Omeros has a
diverse group of preclinical programs and a proprietary G
protein-coupled receptor (GPCR) platform through which it controls
54 new GPCR drug targets and corresponding compounds, a number of
which are in preclinical development. The company also exclusively
possesses a novel antibody-generating platform.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20180810005106/en/
Cook Williams Communications, Inc.Jennifer Cook WilliamsInvestor
and Media Relations360.668.3701jennifer@cwcomm.org
Omeros (NASDAQ:OMER)
Historical Stock Chart
From Mar 2024 to Apr 2024
Omeros (NASDAQ:OMER)
Historical Stock Chart
From Apr 2023 to Apr 2024